Scientific Posters
Toxicokinetics of CBX129801, a Bio active C peptide for Potential Replacement Therapy in Type 1 Diabetic PeripheralNeuropathy, Following Subcutaneous Injection of CBX129801 in Rats in a 6-Month Study with a 7-Week Recovery Period
To assess the toxicokinetics (TK) of CBX129801 in Sprague Dawley
Rats following once weekly subcutaneous injection for 26 doses.
Proof-of-Concept of a Qualitative qPCR Assay for RCL Monitoring
qPCR assays for RCL monitoring are a rapid method to detect and usually quantify lentiviral genes, such as the envelope gene vesicular stomatitis virus G…
In-Cell ELISA Assays to Assess Drug Relative Potency Using the Cytation Imaging Reader for Sample Analysis
Potency assays are crucial characterization tools for almost all biotherapeutics during clinical and pre-clinical development for quality control and market authorization purposes.
Points to Consider in the Development of Activity and Potency Assays for Enzyme Biotherapeutics
The ability of enzymes to remain active outside their source organism makes them an ideal candidate for biotherapeutics.
Qualification of a Neurology 2-Plex B (Nf-L, GFAP) Quanterix Simoa® Assay Using a Novel Approach
Biomarkers associated with neurodegenerative diseases and traumatic brain injuries, including Nf-L (Neurofilament light) and GFAP (Glial fibrillary acidic protein) have been identified as potential prognostic…